Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Lucid Diagnostics Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +6 vs. Q2 2023
- Shares held
- 1.92M
- +51.3K (+2.8%) vs. Q2 2023
- Total value
- $2.24M
- −$350.9K (−13.5%) vs. Q2 2023
- New holders
- 7
- 4 more added
- Sold out
- 1
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUCD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 115 | $65.7M |
| Q1 2026 | 103 | $41.0M |
| Q4 2025 | 89 | $35.0M |
| Q3 2025 | 86 | $35.5M |
| Q2 2025 | 72 | $21.7M |
| Q1 2025 | 49 | $14.0M |
| Q4 2024 | 33 | $2.70M |
| Q3 2024 | 29 | $2.00M |
| Q2 2024 | 34 | $1.64M |
| Q1 2024 | 30 | $1.69M |
| Q4 2023 | 25 | $2.46M |
| Q3 2023 | 24 | $2.24M |
| Q2 2023 | 18 | $2.59M |
| Q1 2023 | 19 | $2.49M |
| Q4 2022 | 23 | $2.60M |
| Q3 2022 | 23 | $3.52M |
| Q2 2022 | 31 | $5.55M |
| Q1 2022 | 32 | $9.09M |
| Q4 2021 | 35 | $17.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Lucid Diagnostics Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hantz Financial Services, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 13 | $15 | 0.00% | +13 | New |
| Qube Research & Technologies Ltd | 104 | $122 | 0.00% | +104 | New |
| Bank of America Corp | 174 | $204 | 0.00% | +174 | New |
| Morgan Stanley | 200 | $234 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1,920 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $2.34K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,991 | $3.50K | 0.00% | +2,964+10,977.8% | Added |
| UBS Group AG | 5,516 | $6.45K | 0.00% | +5,516 | New |
| Byrne Asset Management LLC | 7,210 | $8.00K | 0.01% | +7,210 | New |
| Wells Fargo & Company | 9,077 | $10.6K | 0.00% | +8,983+9,556.4% | Added |
| State Street Corp | 10,521 | $12.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 17,322 | $20.3K | 0.00% | +17,322 | New |
| BlackRock Inc. | 23,741 | $27.8K | 0.00% | −2,563−9.7% | Reduced |
| LPL Financial LLC | 28,400 | $33.2K | 0.00% | +14,000+97.2% | Added |
| Geneos Wealth Management Inc. | 33,850 | $39.6K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 36,166 | $42.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 36,375 | $42.6K | 0.00% | −26,136−41.8% | Reduced |
| Ayrton Capital LLC | 73,907 | $86.5K | 0.59% | +73,907 | New |
| Geode Capital Management, LLC | 131,871 | $154.3K | 0.00% | −11,594−8.1% | Reduced |
| Bridgeway Capital Management, LLC | 135,000 | $157.9K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 158,135 | $185.0K | 0.02% | −40,939−20.6% | Reduced |
| Vanguard Group Inc | 325,566 | $380.9K | 0.00% | +5,733+1.8% | Added |
| Luminus Management LLC | 875,100 | $1.02M | 0.32% | −3,278−0.4% | Reduced |
| Royal Bank of Canada | 0 | $0 | 0.00% | −95−100.0% | Sold out |